British American Tobacco p.l.c. vs Altria
BTI and MO side by side, both in consumer staples. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BTI and MO compare
Altria grew revenue faster over the last twelve months (0.47% versus −0.99% for British American Tobacco p.l.c.).
Altria keeps more of each dollar of sales as profit, with a net margin of 34.5% compared with 30.3% at British American Tobacco p.l.c..
Altria pays a dividend yielding 5.5%; British American Tobacco p.l.c. does not pay one.
Altria scores higher on the StockData Score (15 against 6 for British American Tobacco p.l.c.), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BTI | MO |
|---|---|---|
| Size and price | ||
| Market cap | – | $130B |
| Share price | $61.52 | $78.03 |
| Change, 1 year | 18.9% | 25.9% |
| Change, 5 years | 77.9% | 72.6% |
| Beta (5Y) | 0.23 | 0.17 |
| Employees | 17K | 5,900 |
| StockData Score | ||
| Total score | 6 | 15 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 5 (better) | 4 |
| Health score | 0 | 2 (better) |
| Dividend score | 0 | 6 (better) |
| Valuation | ||
| P/E | – | 16.1× |
| P/S | – | 5.5× |
| EV/EBITDA | – | 13.4× |
| P/FCF | – | 14.4× |
| PEG | – | 1.81 |
| FCF yield | – | 7.0% |
| Fair value | – | $75.38 |
| Margin of safety | – | −3.5% |
| Growth | ||
| Revenue growth (TTM) | −0.99% | 0.47% (better) |
| Revenue growth, 5Y average | −0.13% (better) | −2.3% |
| Net income growth (TTM) | 153% (better) | −8.5% |
| EPS growth (TTM) | 157% (better) | −7.6% |
| EPS growth, 5Y average | 4.6% | 11.4% (better) |
| Profitability | ||
| Gross margin | – | 63.3% |
| Operating margin | 39.0% | 47.0% (better) |
| Net margin | 30.3% | 34.5% (better) |
| FCF margin | 22.6% | 38.6% (better) |
| Return on equity | 16.9% | – |
| Return on invested capital | 10.2% | 43.8% (better) |
| Financial health | ||
| Debt / equity | 0.75 | – |
| Net debt / EBITDA | 3.26 | 1.89 (better) |
| Interest coverage | 4.9× | – |
| Current ratio | 0.84 (better) | 0.58 |
| Altman Z-score | – | 5.26 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 5.5% |
| Payout ratio | – | 87.7% |
| Years of dividend growth | 7 | 16 (better) |
| Dividend growth, 5Y average | 2.6% | 4.1% (better) |
| Buyback yield | – | 0.79% |
| Shareholder yield | – | 6.3% |
| Ownership | ||
| Held by institutions | 14.2% | 64.4% |
| Held by insiders | 0.20% | 0.14% |
| Insider net buying, 12 months | – | −$2.3M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | – | 2.3% |
Go deeper
- BTI stock overview
- BTI income statement
- BTI valuation and score
- MO stock overview
- MO income statement
- MO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.